Today was the most buying that's taken place since January 8th when Genta issued 2 U.S. patents for its gallium products franchise. The interesting part is that no news went out today.
I think some prior investors who made money on the last run up to .009 a couple weeks back are getting back in the game for the pending FDA ruling.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.